11 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Advanced Regenerative and REStorative Therapies to combat corneal BLINDNESS (ARREST BLINDNESS)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
Over 30 million Europeans are blind or visually impaired, leading to reduced quality of life and a tremendous loss of productivity in society. Corneal blindness is the second largest cause of blindness globally and while treatable, millions remain unnecessarily blind due to issues of access to transplantable tissue, lack of standardized treatments, and the lag in translating new regenerative medic ...
Voir le projet
14
Participants partenaires
TERMINÉ
Targets and biomarkers for antiepileptogenesis (EPITARGET)
Date du début: 1 nov. 2013, Date de fin: 31 oct. 2018,
Epilepsy is a devastating condition affecting over 50 million people worldwide. This multidisciplinary project is focused on the process leading to epilepsy, epileptogenesis, in adults. Our main hypothesis is that there are combinations of various causes, acting in parallel and/or in succession, that lead to epileptogenesis and development of seizures. Our central premise and vision is that a comb ...
Voir le projet
20
Participants partenaires
TERMINÉ
adaptive model-based Control for laser-assisted Fibre-reinforced tape winding (ambliFibre)
Date du début: 1 sept. 2015, Date de fin: 31 août 2018,
...uct requirements concerning both, material and design. With respect to changing and challenging environmental influences, quick adaptability, failure-free quality and safe operation over the complete life-cycle are mandatory. The successful application of the ambliFibre results will dramatically accelerate the replacement of metal components in these domains, reducing the carbon footprint thanks t ...
Voir le projet
12
Participants partenaires
TERMINÉ
Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration (DRUGSFORD)
Date du début: 1 sept. 2012, Date de fin: 31 août 2016,
Dysregulation of cGMP is a pathological hallmark of inherited retinal degenerations (RD) affecting photoreceptors, the sensory cells of the retina. These RDs, including Retinitis Pigmentosa, Lebers Congenital Amaurosis, and Achromatopsia, are major causes of blindness, affecting approximately one in every 2000 individuals worldwide, and remain without effective treatment. In photoreceptors, cGMP i ...
Voir le projet
6
Participants partenaires
TERMINÉ
NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE (TRANSEURO)
Date du début: 1 janv. 2010, Date de fin: 30 juin 2016,
There are currently no cures for Parkinson's disease (PD) but one of the most effective reparative therapies in patients to date has been with allotransplants of dopamine (DA) neuroblasts obtained from fetal ventral mesencephalic (VM) tissue. However, this cell transplantation approach has given inconsistent results, with some patients doing extremely well and coming off anti-PD medication for yea ...
Voir le projet
15
Participants partenaires
TERMINÉ
Translational Training network on the Cellular and Molecular Bases of Heart Homeostasis and Repair (CardioNeT)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,
The CardioNeT Initial Training Network aims to implement a highly multidisciplinary, intersectoral and competitive training programme in cardiovascular research through cutting-edge projects and extensive training in complementary areas.CardioNeT training comprises two tightly linked components - research and complementary training - that will be implemented at local as well as network level and ...
Voir le projet
13
Participants partenaires
TERMINÉ
The lab-free CBRN detection device for the identification of biological pathogens on nucleic acid and immunological level as lab-on-a-chip system applying multisensor technologies (MULTISENSE CHIP)
Date du début: 1 juin 2011, Date de fin: 30 nov. 2015,
The goal of MultiSENSE is the development of a detection and identification system for biological pathogens, which shall include both the sample preparation stage, during which target molecules are extracted directly and in parallel the ensuing nucleic-acid-based and/or immunological detection and identification steps, in order to build an integrated “sample in, result out” system. Disruptive tech ...
Voir le projet
9
Participants partenaires
TERMINÉ
Sharing capacity across Europe in high-throughput sequencing technology to explore genetic variation in health and disease (GEUVADIS)
Date du début: 1 oct. 2010, Date de fin: 31 déc. 2013,
"High-throughput next-generation DNA sequencing technologies allow investigators to sequence entire human genomes at an affordable price and within a short time frame. The correct interpretation, storage, and dissemination of the large amount of produced genomics data generate major challenges. Tackling these challenges requires extensive exchange of data, information and knowledge between medical ...
Voir le projet
17
Participants partenaires
TERMINÉ
Identifying and validating pre-clinical biomarkers for diagnostics and therapeutics of Neuromuscular Disorders (BIO-NMD)
Date du début: 1 déc. 2009, Date de fin: 30 nov. 2012,
...be ready for ongoing and further clinical trials for the patient benefit. This will increase the therapy efficacy and efficiency and also reduce adverse effects, with impact on patients’ quality of life with also economical relevance.The BIO-NMD consortium is led by the University of Ferrara, an internationally recognised university in the field of genomics of hereditary neuromuscular disorders. I ...
Voir le projet
15
Participants partenaires
TERMINÉ
REvolutionary Approaches and Devices for Nucleic Acid Analysis (READNA)
Date du début: 1 juin 2008, Date de fin: 30 nov. 2012,
"The REvolutionary Approaches and Devices for Nucleic Acid analysis – READNA – consortium is composed of researchers from 10 academic institutions, 5 SMEs and 3 large companies. The goals of the READNA consortium are to revolutionize nucleic acid analysis methods, by 1) improving elements necessary to use the currently emerging generation of nucleic acid sequencers in a meaningful and accessible w ...
Voir le projet
20
Participants partenaires
TERMINÉ
Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)
Date du début: 1 févr. 2008, Date de fin: 31 janv. 2011,
...ses sustainability due to the lack of long-term funding. BBMRI will comprise: • biobanks of different formats (collections of blood, DNA, tissue, etc., together with medical, environmental, life-style and follow-up data), • biomolecular resources (antibody and affinity binder collections, ORF clone collections, siRNA libraries, proteins, cellular resources etc.), • enabling technologies and high-t ...
Voir le projet